Amgen Breakfast Symposium: Strike early and strike strong: LDL-C reduction in very high-risk ASCVD patients.
Tracks
Arrhythmia / EP
Mechanisms and Preclinical Discovery
Clinical / Surgical
Heart Failure
Imaging
Multidisciplinary
Paediatrics / Adult Congenital
Other
EHJ / HLC
ANZET
| Friday, August 2, 2024 |
| 7:15 AM - 8:15 AM |
| Meeting Room 2 |
Speaker
Prof Stephen Nicholls
Director
Monash Healh / Monash University
Strike early and strike strong: LDL-C reduction in very high-risk ASCVD patients.
7:15 AM - 8:15 AMBiography
MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
Director of Victorian Heart Hospital, MonashHeart & ICU, Monash Health Director of Victorian Heart Institute, Monash University Professor of Cardiology, Monash University Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023.
Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations. His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. He is Chair of the Asia Pacific Cardiometabolic Consortium, President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.
Director of Victorian Heart Hospital, MonashHeart & ICU, Monash Health Director of Victorian Heart Institute, Monash University Professor of Cardiology, Monash University Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023.
Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations. His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. He is Chair of the Asia Pacific Cardiometabolic Consortium, President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.
Assoc Prof Peter Psaltis
Deputy Director, Co-leader, Lifelong Health Theme, Leader, Heart And Vascular Program, SAHMRI
South Australia Health and Medical Research Institute / Central Adelaide LHN / University of Australia
Strike early and strike strong: LDL-C reduction in very high-risk ASCVD patients.
7:15 AM - 8:15 AMBiography
A/Prof Peter J Psaltis (MBBS (Hons), PhD, FRACP, FCSANZ, FESC)
A/Prof Peter Psaltis is an academic interventional cardiologist and vascular biologist, who holds Faculty positions at SAHMRI, CALHN and the University of Adelaide. He is the Deputy Director of SAHMRI, co-leads its largest research department, the Lifelong Health Theme of more >310 researchers, and leads its Heart and Vascular Program. Concurrently, he is also Head of Interventional Coronary Services in the Department of Cardiology, Royal Adelaide Hospital. Among other leadership positions, Peter is a Board Director of the Australian Cardiovascular Alliance and Co-Chair of its Coronary Artery Disease Working Group.
Peter has expertise across all three disciplines of basic, translational, and clinical research and leads bench-to-bedside projects spanning topics of developmental macrophage biology, vascular stem cells, inflammatory regulation of atherosclerosis, pharmacological modification of atherosclerosis, coronary plaque imaging, the modelling of biomechanical forces in coronary arteries and cardiometabolic disease.
A/Prof Peter Psaltis is an academic interventional cardiologist and vascular biologist, who holds Faculty positions at SAHMRI, CALHN and the University of Adelaide. He is the Deputy Director of SAHMRI, co-leads its largest research department, the Lifelong Health Theme of more >310 researchers, and leads its Heart and Vascular Program. Concurrently, he is also Head of Interventional Coronary Services in the Department of Cardiology, Royal Adelaide Hospital. Among other leadership positions, Peter is a Board Director of the Australian Cardiovascular Alliance and Co-Chair of its Coronary Artery Disease Working Group.
Peter has expertise across all three disciplines of basic, translational, and clinical research and leads bench-to-bedside projects spanning topics of developmental macrophage biology, vascular stem cells, inflammatory regulation of atherosclerosis, pharmacological modification of atherosclerosis, coronary plaque imaging, the modelling of biomechanical forces in coronary arteries and cardiometabolic disease.
